NPY and obesity disorder: This process, in turn, reduces the activity of the orexigenic neuropeptide Y (NPY) in the hypothalamus and the neurons in the nucleus of the solitary tract (NTS) and the dorsal vagal complex (DVC) through the gut–brain axis, leading to decreased food intake and increased satiety, ultimately preventing obesity and fat accumulation.